Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

John Rice - aVenture Research

John Rice

AddedMar 31, 2024

UpdatedOct 18, 2026

John Rice

John Rice

Co-Founder, Triathlon Medical Venture Partners

John Rice's Career

Triathlon Medical Venture Partners

Investment Firm

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Cincinnati, OH, US

Co-Founder

Xact Medical

Series A$225kCincinnati, OH, US

Board Member· Board

Kereos

Series B$27.2MSt. Louis, MO, US

Board Member· Board

Kurome Therapeutics

Series A$15MCincinnati, OH, US

Board Member· Board

Eccrine Systems

Series B$27.9MCincinnati, OH, US

Board Member· Board

Airway Therapeutics

Series C$38.8MCincinnati, OH, US

Board Member· Board

Genetesis

Series C$35.8MMason, OH, US

Board Member· Board

Enable Injections

Series C$347MCincinnati, OH, US

Board Member· Board

People Similar to John Rice

Thomas DyrbergBoard Member · AlloCure

Jon SaxeBoard Member · VistaGen Therapeutics

Brian BirkBoard Member · Sun Mountain Capital

Christy ShafferBoard Member · Clearside Biomedical

Darlene Deptula-HicksBoard Member · Aerami Therapeutics

Aaron FletcherCo-Founder · Bios Partners

Rishi GuptaBoard Member · Aer Therapeutics

Leadership at Triathlon Medical Venture Partners

Dennis B CostelloCo-Founder

Similar to Triathlon Medical Venture Partners

Mediphase Venture PartnersNewton, MA, USest. 1999Mediphase Venture PartnersNewton, MA, US · est. 1999

Mediphase Venture Partners: A US-based venture capital firm specializing in healthcare and life sciences.

Investment Firm7

TriStar Health PartnersNashville, TN, USest. 2009TriStar Health PartnersNashville, TN, US · est. 2009

TriStar Health Partners: A Nashville-based venture capital firm investing in early-stage healthcare innovations since 2009.

Investment Firm2

Twilight Venture PartnersIndianapolis, IN, USest. 2002Twilight Venture PartnersIndianapolis, IN, US · est. 2002

Twilight Venture Partners, LLC: A venture capital firm investing in biotech, healthcare, and related services.

Investment Firm5

Triage VenturesSan Francisco, CA, USTriage VenturesSan Francisco, CA, US

Triage Ventures: A US-based venture capital firm specializing in technology, data, and cloud sectors.

Investment Firm5

Leadership at Xact Medical

Andrew CothrelCEO

Similar to Xact Medical

IntuiTap MedicalChicago, IL, USMedical Devicesest. 2016IntuiTap MedicalChicago, IL, US · est. 2016

IntuiTap Medical: Innovating medical devices for precise spinal taps and epidurals.

Series A · $7.5M6

Actuated MedicalBellefonte, PA, USMedical Devicesest. 2006Actuated MedicalBellefonte, PA, US · est. 2006

Actuated Medical, based in Bellefonte, US, specializes in R&D, design, and manufacturing of medical devices.

Angel · $1.6M33

Intact MedicalFramingham, MA, USMedical Devicesest. 2002Intact MedicalFramingham, MA, US · est. 2002

US-based Intact Medical Corp. develops minimally invasive systems.

Series G · $25.7M7

FastWave MedicalMaple Grove, MN, USMedical Devicesest. 2021FastWave MedicalMaple Grove, MN, US · est. 2021

FastWave Medical: Innovating efficient intravascular lithotripsy devices.

Series B · $31M5

Leadership at Kereos

Gregory LanzaCo-Founder

Samuel WicklineBoard Member

Gary StevensonBoard Member

Greg JohnsonBoard Member

Fred M. SchwarzerBoard Member

Dr Michael D LobergBoard Member

Similar to Kereos

Cell PointCentennial, CO, USBiopharmaceuticals, Molecular Imagingest. 2001Cell PointCentennial, CO, US · est. 2001

Cellpoint LLC: A Colorado-based biotech firm offering molecular imaging and comprehensive biopharmaceutical services.

Series A · $23.7M11

Leadership at Kurome Therapeutics

Daniel HellerBoard Member

Jan RosenbaumCEO

Daniel StarczynowskiBoard Member

Similar to Kurome Therapeutics

ImageneBioBoston, MA, USCancer Therapiesest. 2016ImageneBioBoston, MA, US · est. 2016

Ikena: A targeted oncology firm developing novel therapies to combat cancer's formation and spread.

Public · $209M68

Umoja BiopharmaSeattle, WA, USCancer Therapyest. 2019Umoja BiopharmaSeattle, WA, US · est. 2019

Umoja: Innovating cancer therapy by enhancing the body's natural defense system.

Series B · $263M203

Palm TherapeuticsSan Diego, CA, USCancer Treatmentest. 2018Palm TherapeuticsSan Diego, CA, US · est. 2018

Revolutionizing cancer treatment with next-gen root-level therapeutics.

Rome TherapeuticsBoston, MA, USCancer Therapiesest. 2020Rome TherapeuticsBoston, MA, US · est. 2020

ROME Therapeutics develops innovative therapies for cancer and autoimmune diseases using uncharted genetic material.

Series B · $199M64

Leadership at Eccrine Systems

Jason HeikenfeldCo-Founder

Robert BeechBoard Member

Gavi BegtrupCEO

Similar to Eccrine Systems

SweatIDAkron, OH, USWearable Sensorsest. 2017SweatIDAkron, OH, US · est. 2017

SweatID develops wearable fabric sensors for real-time hydration and health monitoring.

Pre-Seed · $631k7

DIANewark, NJ, USBiomarker Sensors, Health Monitoring Devices, Mobile Health Appest. 2021DIANewark, NJ, US · est. 2021

Dia develops non-invasive electrochemical sensors for real-time biomarker analysis in sweat or saliva, relayed via a smartphone app.

Pre-Seed · $480k6

Persperion DiagnosticsSan Diego, CA, USMedical Devicesest. 2022Persperion DiagnosticsSan Diego, CA, US · est. 2022

San Diego-based Persperion Diagnostics Inc. develops non-invasive sweat biomarker sensing tech.

Oxpecker LabsHealth Tech, Sweat Sensorsest. 2016Oxpecker Labsest. 2016

Oxpecker Labs: A deep tech firm innovating non-invasive sweat sensors for health and industrial use.

Leadership at Airway Therapeutics

Marc SalzbergCEO

Mark CollarFounder

Similar to Airway Therapeutics

Aqualung TherapeuticsTucson, AZ, USTherapeutic Antibodiesest. 2010Aqualung TherapeuticsTucson, AZ, US · est. 2010

Aqualung Therapeutics: Biotech firm developing antibodies to combat lung diseases.

Seed · $22.3M6

Aer TherapeuticsRaleigh, NC, USBiopharmaceuticalsest. 2014Aer TherapeuticsRaleigh, NC, US · est. 2014

Aer Therapeutics: Clinical-stage biopharma developing treatments for severe respiratory diseases.

Series A · $36M12

Alveolus BioBirmingham, AL, USBiotherapeuticsest. 2020Alveolus BioBirmingham, AL, US · est. 2020

Alveolus Bio: Innovating FDA-approved therapeutics for lung diseases.

Avalyn PharmaSeattle, WA, USPharmaceuticalsest. 2011Avalyn PharmaSeattle, WA, US · est. 2011

Avalyn Pharma Inc.: Developing innovative therapies for Idiopathic Pulmonary Fibrosis.

Public · $272.5M27

Leadership at Genetesis

Bill BaumelBoard Member

Manny SetegnCo-Founder

Anil AchyutaBoard Member

Mike HoovenBoard Member

Vineet ErasalaCo-Founder

Peeyush ShrivastavaCo-Founder

Similar to Genetesis

HeartVistaPalo Alto, CA, USMedical Imagingest. 2012HeartVistaPalo Alto, CA, US · est. 2012

HeartVista: Streamlining MRI diagnostics with one-click, machine learning-enhanced imaging technology.

Series A · $8.7M16

Leadership at Enable Injections

Norman WeldonCo-Founder

Mr. Michael Hooven D.CEO

Similar to Enable Injections

ApiJect SystemsStamford, CT, USMedical Devicesest. 2018ApiJect SystemsStamford, CT, US · est. 2018

ApiJect Systems Corp., a CT-based medical firm, produces single-use prefilled injectors for pharmaceuticals and biotech.

Portal InstrumentsCambridge, MA, USMedical Devicesest. 2012Portal InstrumentsCambridge, MA, US · est. 2012

Portal Instruments: A Series A funded, early-stage company specializing in medical devices.

Series B · $49M37

Inson Medical SystemsBellevue, WA, USDrug Deliveryest. 2007Inson Medical SystemsBellevue, WA, US · est. 2007

Inson Medical Systems develops and commercializes innovative drug delivery solutions, based in Bellevue, WA since 2007.

Public · $642.5k2

DiavibeProvidence, RI, USMedical Devicesest. 2010DiavibeProvidence, RI, US · est. 2010

Diavibe: An early-stage medical device firm developing drug-free technology to ease injection pain.

Keros TherapeuticsLexington, MA, USBiopharmaceuticalsest. 2015

Keros TherapeuticsLexington, MA, US · est. 2015

Keros Therapeutics: A global biotech firm innovating treatments for hematological and musculoskeletal disorders.

Public · $230M105

ABT Molecular ImagingLouisville, TN, USImaging Drugsest. 2006ABT Molecular ImagingLouisville, TN, US · est. 2006

ABT Molecular Imaging, based in Louisville, US, produces on-site molecular imaging drugs for PET scans.

Series C · $28.4M31

Vergent BioscienceMinneapolis, MN, USImaging Agentsest. 2016Vergent BioscienceMinneapolis, MN, US · est. 2016

Vergent Bioscience: Pioneering in tumor-targeted molecular imaging for cancer surgery.

Series B · $34.4M13

Myocardial SolutionsMorrisville, NC, USMedical Softwareest. 2016

Myocardial SolutionsMorrisville, NC, US · est. 2016

Revolutionizing cardiac MRI testing with swift, precise, and user-friendly software solutions.

Series C · $31.2M37

MagBiosenseSt. Louis, MO, USMedical Devicesest. 2013MagBiosenseSt. Louis, MO, US · est. 2013

MagBiosense develops breakthrough diagnostic devices for rapid, one-step heart attack detection at point-of-care.

Dyad MedicalBoston, MA, USCardiac Imaging, Softwareest. 2018Dyad MedicalBoston, MA, US · est. 2018

Dyad Medical: Pioneering cardiac imaging software for optimized clinical decisions and research, based in Boston.